As a newer treatment , Tirzepatide is still undergoing clinical studies, and while the results so far have shown promising outcomes, there is less long-term, peer-reviewed research on Tirzepatide compared to Semaglutide
Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of a-331440 with improved safety and efficacy
10.1146/annurev.me.39.020188.002341 61 LiD
Among these, two randomized controlled trials (RCTs) examined the direct impact of GLP-1 RAs on alcohol intake
The Body Pharm Retatrutide 64mg injection pen is a UK-dispatched multi-dose research format containing twice the total peptide capacity of the 32mg pen, designed for in vitro and laboratory protocols requiring extended titration simulations of the GIP, GLP-1 and glucagon triple-receptor agonist LY3437943 [7]
Side effects from this can be mild